Spodumene prices have come under pressure in recent weeks, and we have cut our near-term price outlook for the commodity, downgrading our price forecasts by 15-20% through to the end of 2025. The weaker outlook has driven cuts of 21% and 10% to group earnings for FY25 and FY26. The weaker spodumene price outlook hasRead more
Argonaut | The Natural Choice in Resources.
© 2024 Argonaut.